In this study, we found that myeloid Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (CITED2) promotes BCL6 signaling to limit the expression of inflammatory gene targets and the pathogenesis of diet-induced obesity and metabolic dysfunction. Here, CITED2 is linked to obesity disorder.